Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2012
09/04/2012US8257703 Anti-ganglioside antibodies and compositions
09/04/2012CA2674028C Recombinant b. pseudomallei adhesin protein and methods and uses thereof
09/04/2012CA2483945C Method for simultaneously detecting an antigen and an antibody of an infectious microorganism
09/04/2012CA2432971C Polypeptides
09/04/2012CA2384437C Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis
08/2012
08/30/2012WO2012115241A1 Fcγriib-specific fc antibody
08/30/2012WO2012114339A1 High affinity molecules capable of binding a type a plexin receptor and uses of same
08/30/2012WO2012113927A1 Novel superactive il-33 fragments, and uses thereof
08/30/2012WO2012113863A1 Method of production of sialylated antibodies
08/30/2012WO2012113813A1 Antibodies against human il33r and uses thereof
08/30/2012WO2012113785A1 Methods for treating and diagnosing disease
08/30/2012WO2012113783A1 Method for treating liver inflammation, fibrosis and non-alcoholic steatohepatitis.
08/30/2012WO2012113775A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
08/30/2012WO2012113718A1 A diagnostic method for type ii diabetes
08/30/2012WO2012113348A1 Anti-cd4 protein monoclonal antibody, active fragments and uses thereof
08/30/2012WO2012113266A1 Antibody and antigen recognizing tumor-initiating cells and use thereof
08/30/2012WO2012094623A3 Anti-il-12/il-23 antibodies and uses thereof
08/30/2012WO2012085872A3 Stable immunogenic compositions of staphylococcus aureus antigens
08/30/2012WO2012031099A9 Anti-cxcl13 antibodies and methods of using the same
08/30/2012WO2012017082A3 Anti-la antibodies and their use for immunotargeting
08/30/2012WO2012016107A8 Methods and kits for detection of salmonella enteritidis and related serovars
08/30/2012US20120220758 Antibody having activity of inhibiting hepatitis c virus (hcv) infection and use thereof
08/30/2012US20120220754 Methods for generating radioimmunoconjugates
08/30/2012US20120220517 Glycopegylation Methods and Proteins/Peptides Produced by the Methods
08/30/2012US20120219990 Pre-filtration adjustment of buffer solutes
08/30/2012US20120219977 Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
08/30/2012US20120219976 Reducing the risk of human anti-human antibodies through v gene manipulation
08/30/2012US20120219973 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
08/30/2012US20120219972 Diagnosis and treatment of ehrlichiosis
08/30/2012US20120219969 Marker for neuromyelitis optica
08/30/2012US20120219965 Masp 2, a complement-fixing enzyme, and uses for it
08/30/2012US20120219578 Neisserial antigenic peptides
08/30/2012US20120219569 Use of an anti-cd151 antibody in the treatment of cancer
08/30/2012US20120219565 Engineered anti-tslp antibody
08/30/2012US20120219564 Human Antibodies That Bind Human TNFalpha
08/30/2012US20120219560 DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
08/30/2012US20120219558 Antagonists of pcsk9
08/30/2012US20120219557 Human monoclonal antibodies to protein tyrosine kinase 7 (ptk7) and methods for using anti-ptk7 antibodies
08/30/2012US20120219553 Use of a cd258 binding pharmaceutical substrance for making a pharmaceutical composition with dose-dependent effect
08/30/2012US20120219552 Antibody recognizing turn structure in amyloid beta
08/30/2012US20120219551 Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
08/30/2012US20120219547 Humanized Anti-TNFalpha Antibodies
08/30/2012US20120219542 Podocyte ph modulation and uses thereof
08/30/2012US20120219504 Complex of a protein comprising zinc oxide-binding peptides and zinc oxide nanoparticles, and use thereof
08/30/2012US20120219503 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/30/2012US20120219501 Biomarker en2 for gynaecological cancer
08/30/2012CA2827983A1 Novel superactive il-33 fragments, and uses thereof
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/30/2012CA2827637A1 Novel modulators and methods of use
08/30/2012CA2824500A1 Antibodies against human il33r and uses thereof
08/29/2012EP2492283A1 Immunoabsorbed anti-staphylococcal enterotoxins polyclonal antibodies, preparation and uses thereof
08/29/2012EP2492278A1 Antibodies against an agonist of G-protein coupled receptors and its use indiagnosis and therapy
08/29/2012EP2491945A1 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
08/29/2012EP2491397A1 NON-CROSS-REACTIVE ANTI IgG ANTIBODIES
08/29/2012EP2491394A2 Surface-assisted hemagglutination and hemagglutination inhibition assays
08/29/2012EP2491129A2 Dual variable domain immunoglobulins and uses thereof
08/29/2012EP2491059A1 Anti-hepsin antibodies and methods using same
08/29/2012EP2491058A1 Modulators of hepatocyte growth factor activator
08/29/2012EP2491057A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
08/29/2012EP2491056A1 Vhh for application in tissue repair, organ regeneration, organ replacement and tissue engineering
08/29/2012EP2491055A2 Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
08/29/2012EP2490780A1 Use of mixed mode chromatography for the capture and purification of basic antibody products
08/29/2012EP2490721A1 Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions
08/29/2012EP2490719A2 Methods of using anti-cd3 antibodies to prevent weight gain
08/29/2012EP2490714A2 Anti-cd3 antibody dosing in autoimmune disease
08/29/2012CN202400999U High-reflux rapid antibody purifying device
08/29/2012CN1997751B Antibodies and related molecules that bind to PSCA proteins
08/29/2012CN1976950B Anti-CD38 human antibodies and uses therefor.
08/29/2012CN1841066B Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/29/2012CN1826130B Use of a PAK inhibitor for the treatment of a joint disease
08/29/2012CN1678633B Anti-IGF-I receptor antibody
08/29/2012CN102652139A Pcsk9 antagonists
08/29/2012CN102649818A CD4 protein-resistant monoclonal antibody and active fragment and application thereof
08/29/2012CN102649817A Monoclonal antibody for inhibiting formation of bacterial biofilm
08/29/2012CN102649816A Application of high mobility group box (HMGB) protein and antibody to preparation of ostrea rivularis anti-infection immune preparation
08/29/2012CN102649815A Application of AIF1 (Allograft Inflammatory Factor 1) protein and antibody to preparing southern oyster anti-infectious immune preparation
08/29/2012CN101928345B Human source antibody and humanization remolding method thereof
08/29/2012CN101701033B Methods for preparing antigen, antibody and sample of Eperythrozoon suis
08/29/2012CN101633694B Method for preparing polyclonal antibody against mouse nerve growth factor (NGF) and application thereof
08/29/2012CN101631854B Laccases for pulp bio-bleaching
08/29/2012CN101318019B Compositions and methods for the therapy of inflammatory bowel disease
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/29/2012CN101023100B Her2 antibody composition
08/28/2012US8252915 Human transferase family members and uses thereof
08/28/2012US8252908 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases
08/28/2012US8252907 Methods and compositions for inhibiting binding of IgE to a high affinity receptor
08/28/2012US8252906 Anti-herpes simplex virus antibodies and methods of use thereof
08/28/2012US8252905 Anti-CD14 antibody fusion protein
08/28/2012US8252904 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer
08/28/2012US8252903 Human sarcoma-associated antigens
08/28/2012US8252902 Complexing antigen, antibodies; immunoassay
08/28/2012US8252901 Membrane fusion proteins derived from reovirus
08/28/2012US8252897 Modified toxins
08/28/2012US8252896 Process for making bivalirudin
08/28/2012US8252894 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof
08/28/2012US8252893 CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
08/28/2012US8252727 Antibody diversity generation
08/28/2012US8252584 Adiponectin receptor and gene encoding the same
08/28/2012US8252545 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
08/28/2012US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 1494